Van Cutsem, E <br/><br/>
[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials].  [electronic resource] 

 -  Bulletin du cancer  Dec 1998 
 - 33-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0007-4551 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Camptothecin--adverse effects<br/>Clinical Trials, Phase II as Topic<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Enzyme Inhibitors--adverse effects<br/>Europe<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Palliative Care<br/>Remission Induction<br/>Salvage Therapy<br/>Topoisomerase I Inhibitors<br/>Treatment Outcome<br/>United States